Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
6
×
Tags
biotech
6
×
boston blog main
clinical trials
life sciences
national blog main
rna interference
6
×
boston top stories
national top stories
alnylam pharmaceuticals
deals
fda
new york blog main
new york top stories
regeneron pharmaceuticals
amgen
boston
san francisco blog main
san francisco top stories
alexion pharmaceuticals
alirocumab
arrowhead pharmaceuticals
boehringer ingelheim
drugs
eli lilly
evolocumab
hepatitis b
hereditary transthyretin amyloidosis
inclisiran
indiana blog main
indiana top stories
new york
patisiran
pcsk9 inhibitors
roche
san diego blog main
san diego top stories
wisconsin blog main
wisconsin top stories
a2 biotherapeutics
aduro biotech
What
medicines
drug
rna
ago
alnylam
cholesterol
deal
dicerna
fda
long
medco
new
pharma
pharmaceuticals
rnai
time
abandoning
acquire
agreed
alliance
approve
awaits
baggage
based
billion
bio
biological
brings
bristol
buy
calls
cash
caught
causing
changing
color
companies
company
compound
crispr
Language
unset
Current search:
photo
×
" rna interference "
×
biotech
×
@xconomy.com
3 years ago
Bio Roundup: CRISPR Kudos, Bristol Myers’s Buy, RNAi Alliance & More
@xconomy.com
4 years ago
Novartis to Acquire MedCo and FDA-Ready Cholesterol Drug for $9.7B
@xconomy.com
4 years ago
Roche to Pay Dicerna Pharma $200M to Team Up on Hepatitis B Drug
@xconomy.com
5 years ago
MedCo Touts New Data for Long-Lasting Heart Drug as Reckoning Looms
@xconomy.com
5 years ago
Free of Baggage, Dicerna Cuts Another RNAi Deal and Gets $200M
@xconomy.com
5 years ago
Patients Have “Fingers Crossed” As Alnylam Awaits Historic FDA Decision